Annex
AMI Metrics Catalogue
PQMD recommends the three priority indicators as a shared starting point. The AMI Metrics Catalogue includes additional output and outcome measures to consider, and PQMD is committed to the future development of AMI.
No metric matches. Clear the search or choose All to see the whole catalogue.
| Metric ID | Metric name | Output / Outcome | Impact area |
|---|---|---|---|
| 1.A |
Percent of priority product demand met through available supplyPriority metricWhat this represents This measure will help organizations to understand whether the donated products align with and help fulfill priority product demands. It helps show the gap between what has been identified as a priority and what ultimately becomes available through donated supply for use. Why it matters Shows how responsive the donation system is to local health partner priorities and helps build stronger partnerships and more consistent pipelines of priority products. This metric helps organizations see where donated supply is meeting identified demand, where gaps remain. This understanding drives deeper understanding of trends in priorities, as well as where sourcing, donor engagement, planning, or partnership decisions may need to change. Open the metric card |
Outcome | Availability of Product |
| 2.A |
Stockout-Free Reporting Periods, for Priority ProductsPriority metricWhat this represents Stockouts interrupt care delivery, delay treatment, and place strain on providers and facilities. Donated products help provide product access. Stockout-free reporting periods help show whether donated products contribute to sufficient/ consistent product supplies to support continuity of care. This metric also informs where recurring or prolonged interruptions may prompt larger conversations about in supply, expectations, planning, or partnership. Why it matters Stockouts interrupt care delivery, delay treatment, and place strain on providers and facilities. Open the metric card |
Outcome | Continuity of Care |
| 3.A |
Percent Change in the Volume of Product-Supported Health Services DeliveredPriority metricWhat this represents Reflects improvements in access to care, as a result of medical product provision, either directly or indirectly. Captured by comparing facility/site utilization. Why it matters Medical product donations create value when they enable care. Tracking the availability of product-supported health services moves the evidence beyond products delivered to what local/in-country partners are able to provide to patients and communities. Open the metric card |
Outcome | Capacity to Deliver Care |
| 1.1 |
Quantity and type of products requested by local health partnersWhat this represents This metric represents demand/need by type of product that donors placed with local health partners, and context around it’s availability via gaps in local procurement, costly, or other reasons relating to availability, affordability, and access. Why it matters Quantifying product demand/need by trusted local health partners is an important approach to understanding true community need. |
Output | Availability of Product |
| 1.3 |
Financial cost of shipping and distributionWhat this represents Represents the step-by-step transportation and logistics costs to deliver medical products from supplier to facilities/NGO implementers. Why it matters Donations cannot be utilized unless they are successfully delivered to local health partners, and this key process has real costs that must be budgeted for and tracked. |
Output | Availability of Product |
| 1.4 |
Average time, in days, from receipt of donation need to donation ship dateWhat this represents This would track the responsiveness and efficiency of donors/ suppliers to meet expressed need with available product. For available products, this would be the turnaround time in days for when the product is fulfilled in the donor logistics system. Why it matters Delivering donations where they are needed in timely manner is crucial for serving community health needs, as well as avoiding donation waste for products that expire . |
Output | Availability of Product |
| 1.5 |
Percent of donations with sufficient dating, and correct documentation for supporting donationWhat this represents This reflects the minimum information necessary to effectively import, store, use, and maintain donations An output metric could be created for each area listed, and could be decided on depending on the product type. Why it matters Donations must be accompanied by a minimum amount of information to allow for correct management (clearance, storage, use, maintenance). Use by dates help organizations prioritize use and destruction. Without proper dating on products, and inclusion of important documentation to ensure safe use among communities, donations risk being wasted. |
Output | Availability of Product |
| 1.6 |
Percent and days of shelf life , by donation prodcut category, remaining at each stage of the product journeyWhat this represents PQMD is completing this description. Why it matters PQMD is completing this description. |
Outcome | Availability of Product |
| 1.7 |
Number of countries and sub-country level geographies served/reachedWhat this represents Represents geographic reach across the globe, as well as in-country breadth of coverage Why it matters This is a high-level measure of geographic access, allowing easy comparison and aggregation across program and project types. |
Output | Availability of Product |
| 1.8 |
Quantity of product delivered to each partner over timeWhat this represents This represents the product provided to the final organizational recipient. Why it matters This metric demonstrates the scale of donations verified to reach trusted local health partners. |
Output | Availability of Product |
| 1.9 |
Quantity of product destroyed, and reason over time (e.g. expired, improperly stored, etc.)What this represents Product unused, wasted (negative). Reflects quantity utilized on-time/ within use window. The units of measure can be weight, units of individual product, doses, kits, packages.Suppliers/donors, NGO distributors, and NGO/facility implementers would be responsible for reporting. Why it matters It is important to understand how much of donated products are not utilized as intended (i.e. in the provision of care for someone in need), and what factors contributed to the waste of that treatment opportunity. |
Output | Availability of Product |
| 1.2 |
Number of consecutive years of supply of necessary medicines and productsWhat this represents This reflects the ability of the donation system to consistently meet national level/population priority needs. On a country-specific basis, identify needed medicines/products and whether or not they are being provided via a donation program NGO/Facility implementer would report this. Why it matters PQMD is completing this description. |
Output | Availability of Product |
| 1.B |
Percent of local health partners achieving or staying below an [industry-determined] destruction percentage of donated productWhat this represents This would showcase the timeliness and effectiveness of the donation process, with an emphasis on the quality of the process. While it would summarize the “end of the product journey”, it is a metric that is shared by all member types (donor, distributor, implementer). Why it matters Low wastage by local health partners signifies well-matched supply to utilization projections, and sufficient long-dating of products to allow flexible utilization over time. While the metric is assessed at the “end of the product journey”, it is collectively shared by all partners and reflects good communication, quality product donation practices, and strong systems. |
Outcome | Availability of Product |
| 2.1 |
Number of local health partners supported by donation programsWhat this represents Reach of locations where donations are utillized. NGO distributor would be responsible for reporting. Why it matters This quantifies the organizations responsible for processing donations at the last step of the donation chain before they are utilized by patients. |
Output | Continuity of Care |
| 2.2 |
Number of partnerships betweenl health partners, and average length of active partnershipsWhat this represents Reflects the coverage and strength of relationships necessary for local organizations to secure quality products, consistently. Why it matters The quantity of partnerships between NGOs and local health organizations represents the network that facilitates access. The length of partnerships is a proxy for strength of relationships necessary for local organizations to secure quality products consistentl. |
Output | Continuity of Care |
| 2.B |
Percent of partnerships that maintain or change the scale, scope, or value of delivered products year-over-year.What this represents Reflects the growth in partnerships as measured by sustained donations, increasing donation quantity, increasing donation product diversity, or increasing donation value. Why it matters This represents increased commitments as a function of the relationship and trust built over time. |
Outcome | Continuity of Care |
| 3.1 |
Number of individuals or patients treated/supported/reached with donated productsWhat this represents Reflect the reach of the, attributable, to donated product. Why it matters This metric highlights the strength of access that a local health partner has to community members and highlights a baseline potential for understanding future donation potential. |
Output | Capacity to Deliver Care |
| 3.2 |
Number of healthcare workers trained as part of a donated product programWhat this represents Count of health workers trained as component of a product donation program. This would be more applicable to donation programs centered around specific products or devices that require training for correct utilization. Why it matters This metric captures a key component of health systems strengthening that may be directly affected as a result of a product donation program. |
Output | Capacity to Deliver Care |
| 3.B |
Percent year-over-year change in local health partner capacity by donation implementation support area, including: workforce capability; physical infrastructure; inventory tracking systems; device/product maintenance capacityWhat this represents This metric reflects the changes that result either directly or indirectly from medical product donations and medical donation partnerships. There are areas of a local health organization’s capacity that are influenced and can develop as a function of the provision of a donation. Why it matters This metric is important for estimating and understanding how product donations can influence and contribute to service provider systems strengthening, and how improvements in capacity can influence how local health partners plan for future service delivery. |
Outcome | Capacity to Deliver Care |
Health & Quality Outcomes
Health and quality outcomes may extend the impact story for programs with a sufficiently clear and credible line of contribution. They are not a fourth shared AMI impact area and are not standardized through this supporting catalogue.
| Metric ID | Metric name | Output / Outcome |
|---|---|---|
| 4.A |
Percent change in a specific health status among patients treated with donated productsWhat this represents Reflects the direct effects of donated products on patients receiving or having received treatment with those products Possible options include: disease status (e.g. viral suppression, improved A1C, progression of disease). Why it matters This metric represents human-level health impact, which can have significant knock-on effects across other areas of well-being, quality of life, and livelihoods among individuals and households. |
Outcome |
| 4.B |
Percent change in a health outcomes among a population accessing health services from a local health partnerWhat this represents Reflects the effects of donated products on communities where significant numbers of individual patients are receiving or have received treatment with donated products, the effects could be direct or indirect. Possible options include: Quality Adjusted Life Years, Disability Adjusted Life Years, reduction in disease burden. Publicly available administrative data would be used to track progress. Why it matters This metric represents human-level health impact at scale, which can have significant knock-on effects across other areas of community well-being, quality of life, and livelihoods. |
Outcome |
Not every program should measure health and quality outcomes. Use them where the evidence can credibly support the connection.